Benzinga's M&A Chatter for Monday August 24, 2015

The following are the M&A deals, rumors and chatter circulating on Wall Street for Monday August 24, 2015:

:

Xerox

announced Monday, an agreement to acquire RSA Medical. Terms were not disclosed. The transaction is expected to close in Q3 of 2015. Xerox closed at $9.93 on Monday, down 7%.

:

Southern Company

and AGL Resources

announced Monday, that both companies' boards of directors approved a definitive merger agreement. AGL Resources will become a wholly owned subsidiary of Southern Company in a transaction with an enterprise value of approximately $12 billion, with a total equity value of approximately $8 billion. AGL Resources shareholders will receive $66 per share in cash. The deal is expected to close in H2 of 2016. AGL Resources closed Monday at $61.41 Monday, a gain of 28%.

:

Medivation, Inc.

and BioMarin Pharmaceutical Inc.

announced Monday, that Medivation will acquire all worldwide rights to talazoparib, a highly-potent, orally-available poly ADP ribose polymerase inhibitor currently in a Phase 3 study for the treatment of patients with deleterious germline BRCA 1 or BRCA 2 mutations and locally advanced and/or metastatic breast cancer. Medivation will pay BioMarin $410 million upfront, up to an additional $160 million upon the achievement of regulatory and sales-based milestones and mid-single digit royalties for talazoparib. BioMarin shares fell 5% Monday, closing at $119.68.

:

Monsanto Co

has increased its offer to acquire Syngenta AG

from CHF 449 per share to CHF 470 per share, according to sources as reported by

on Monday. That would value Syngenta at $47 billion. The

had reported earlier in the day that Syngenta's Board was under pressure to consider a Monsanto offer. A Syngenta representative did not immediately respond to a request for comment, A Monsanto representative declined comment. Syngenta rose 6% Monday, closing at $81.37.